| Literature DB >> 31587919 |
Weiwei Cheng1, Shaopeng Wang1, Zhe Zhang1, David W Morgens2, Lindsey R Hayes3, Soojin Lee4, Bede Portz5, Yongzhi Xie1, Baotram V Nguyen5, Michael S Haney2, Shirui Yan1, Daoyuan Dong1, Alyssa N Coyne3, Junhua Yang6, Fengfan Xian1, Don W Cleveland7, Zhaozhu Qiu6, Jeffrey D Rothstein3, James Shorter5, Fen-Biao Gao4, Michael C Bassik2, Shuying Sun8.
Abstract
Hexanucleotide GGGGCC repeat expansion in C9ORF72 is the most prevalent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). One pathogenic mechanism is the aberrant accumulation of dipeptide repeat (DPR) proteins produced by the unconventional translation of expanded RNA repeats. Here, we performed genome-wide CRISPR-Cas9 screens for modifiers of DPR protein production in human cells. We found that DDX3X, an RNA helicase, suppresses the repeat-associated non-AUG translation of GGGGCC repeats. DDX3X directly binds to (GGGGCC)n RNAs but not antisense (CCCCGG)n RNAs. Its helicase activity is essential for the translation repression. Reduction of DDX3X increases DPR levels in C9ORF72-ALS/FTD patient cells and enhances (GGGGCC)n-mediated toxicity in Drosophila. Elevating DDX3X expression is sufficient to decrease DPR levels, rescue nucleocytoplasmic transport abnormalities, and improve survival of patient iPSC-differentiated neurons. This work identifies genetic modifiers of DPR protein production and provides potential therapeutic targets for C9ORF72-ALS/FTD.Entities:
Keywords: ALS; CRISPR-Cas9 screen; DDX3X; FTD; RAN translation; RNA; helicase; neurodegeneration; repeat expansion
Mesh:
Substances:
Year: 2019 PMID: 31587919 PMCID: PMC6895427 DOI: 10.1016/j.neuron.2019.09.003
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 18.688